| scholarly article | Q13442814 |
| P50 | author | Eloisa Bonfa | Q37837127 |
| P2093 | author name string | Sandra Gofinet Pasoto | |
| Victor Adriano de Oliveira Martins | |||
| P2860 | cites work | A Systematic Review of Peripheral and Central Nervous System Involvement of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Primary Sjögren's Syndrome, and Associated Immunological Profiles | Q26774584 |
| Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects | Q27023280 | ||
| Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
| T cell epitope mimicry between Sjögren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria | Q30405454 | ||
| Diagnostic significance of measuring antibodies to cyclic type 3 muscarinic acetylcholine receptor peptides in primary Sjogren's syndrome | Q33393568 | ||
| Sex differences in patients with systemic lupus erythematosus from Northwest Spain. | Q33408763 | ||
| Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome | Q33415769 | ||
| Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature | Q33439455 | ||
| Systemic lupus erythematosus VII: frequency and impact of secondary Sjøgren's syndrome | Q33502888 | ||
| Genome-wide association studies in Sjögren's syndrome: What do the genes tell us about disease pathogenesis? | Q33601647 | ||
| Analysis of Clinical Characteristics of Immune-Related Dry Eye | Q33790701 | ||
| Somatic expression of LINE-1 elements in human tissues. | Q33959421 | ||
| The epidemiology of Sjögren's syndrome | Q34004258 | ||
| EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome | Q34117422 | ||
| American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort | Q34260251 | ||
| Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group | Q34523084 | ||
| Shared signatures between rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome uncovered through gene expression meta-analysis. | Q34968138 | ||
| Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort | Q35426932 | ||
| Association between Secondary and Primary Sjögren's Syndrome in a Large Collection of Lupus Families | Q35889745 | ||
| Elevated Salivary Alpha-Amylase Level, Association Between Depression and Disease Activity, and Stress as a Predictor of Disease Flare in Systemic Lupus Erythematosus: A Prospective Case-Control Study | Q36009350 | ||
| New insights into B cell biology in systemic lupus erythematosus and Sjögren's syndrome | Q36011177 | ||
| Serum cryoglobulins and disease activity in systematic lupus erythematosus | Q37068412 | ||
| High-resolution HLA analysis of primary and secondary Sjögren's syndrome: a common immunogenetic background in Mexican patients | Q85643693 | ||
| Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren's syndrome | Q85856827 | ||
| Autoimmunity: Ro60-associated RNA takes its toll on disease pathogenesis | Q86658116 | ||
| Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain | Q87004596 | ||
| Evidence for the Detection of Subclinical Retinal Involvement in Systemic Lupus Erythematosus and Sjögren Syndrome: A Potential Association with Therapies | Q89105321 | ||
| The Role of Long Non-coding RNAs in the Pathogenesis of RA, SLE, and SS | Q90301434 | ||
| Clinical and immunological parameters of Sjögren's syndrome | Q90919123 | ||
| How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project) | Q91196740 | ||
| Severity of dry eye syndrome is related to anti-dsDNA autoantibody in systemic lupus erythematosus patients without secondary Sjogren syndrome: A cross-sectional analysis | Q37116902 | ||
| X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome | Q37249179 | ||
| Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche | Q37662690 | ||
| Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus | Q37690544 | ||
| Evaluation of Autoantibodies in Patients with Primary and Secondary Sjogren's Syndrome | Q37721340 | ||
| Systemic lupus erythematosus with Sjögren syndrome compared to systemic lupus erythematosus alone: a meta-analysis | Q37966911 | ||
| Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review | Q38015065 | ||
| Update on infections and vaccinations in systemic lupus erythematosus and Sjögren's syndrome | Q38229214 | ||
| A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients | Q38275587 | ||
| Ocular manifestations in systemic lupus erythematosus | Q38436812 | ||
| Role of autoantibody testing | Q38533673 | ||
| The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. | Q38784456 | ||
| Polyautoimmunity in Sjögren Syndrome | Q38901464 | ||
| Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies | Q38915804 | ||
| Nonenzymatic antioxidants in saliva of patients with systemic lupus erythematosus | Q38955230 | ||
| The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome. | Q39033400 | ||
| Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndrome | Q39136567 | ||
| Autoantibodies, detection methods and panels for diagnosis of Sjögren's syndrome | Q39229085 | ||
| A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity. | Q39247284 | ||
| Oral manifestations of lupus. | Q39282453 | ||
| The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic | Q40096791 | ||
| Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study | Q40562190 | ||
| Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families | Q40716909 | ||
| Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus | Q41977234 | ||
| Similarities and differences between primary and secondary Sjögren's syndrome | Q43145661 | ||
| Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study | Q43245408 | ||
| Passive transfer of antibodies to the linear epitope 60 kD Ro 273-289 induces features of Sjögren's syndrome in naive mice | Q44381933 | ||
| Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan | Q45282786 | ||
| Oral mucosa biology and salivary biomarkers | Q46745469 | ||
| Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes | Q47599133 | ||
| Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren's syndrome (secondary Sjögren's syndrome) focusing on autoimmune rheumatic diseases | Q47634458 | ||
| Previous diagnosis of Sjögren's Syndrome as rheumatoid arthritis or systemic lupus erythematosus. | Q48060508 | ||
| Systemic lupus erythematosus and ocular involvement: an overview | Q49833678 | ||
| Identification of a novel autoantibody against self-vimentin specific in secondary Sjögren's syndrome | Q50057851 | ||
| The role of gut microbiota in the pathogenesis of rheumatic diseases | Q50072788 | ||
| New insights into the role of renal resident cells in the pathogenesis of lupus nephritis | Q50102855 | ||
| Neonatal Systemic Lupus Erythematosus Syndrome: a Comprehensive Review | Q50108711 | ||
| The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies | Q50263868 | ||
| Autoantibodies in Sjögren's Syndrome. | Q50926832 | ||
| Role of autoantibodies to various Ro60 epitopes in the decrease of lymphocytes seen in systemic lupus erythematosus and primary Sjögren's syndrome. | Q50987483 | ||
| Predicting Sjögren's syndrome in patients with recent-onset SLE. | Q51063698 | ||
| Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren's syndrome. | Q51332462 | ||
| 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts. | Q51358713 | ||
| Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations. | Q53746240 | ||
| Primary Sjögren's Syndrome. | Q54260597 | ||
| Deoxyribonuclease-Inhibitory Antibodies in Systemic Lupus erythematosus | Q56878308 | ||
| Xerostomia in Sjögren's syndrome and lupus erythematosus: a comparative histological and immunofluorescence study of minor salivary glands alterations | Q56988856 | ||
| Anti-DNase I Antibody: A New Serological Reactivity in Primary Sjögren Syndrome | Q57068360 | ||
| One year in review 2018: systemic lupus erythematosus | Q57121332 | ||
| A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23 | Q57603213 | ||
| An update on the role of type I interferons in systemic lupus erythematosus and Sjögrenʼs syndrome | Q60548049 | ||
| EBV reactivation serological profile in primary Sjögren’s syndrome: an underlying trigger of active articular involvement? | Q61974472 | ||
| Systemic lupus erythematosus disease activity index 2000 | Q77624632 | ||
| Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset | Q83975513 | ||
| Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome | Q85324755 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| lupus erythematosus | Q188297 | ||
| rheumatology | Q327657 | ||
| Sjögren's syndrome | Q335555 | ||
| P304 | page(s) | 33-45 | |
| P577 | publication date | 2019-01-29 | |
| P1433 | published in | Open Access Rheumatology: Research and Reviews | Q15816468 |
| P1476 | title | Sjögren's syndrome and systemic lupus erythematosus: links and risks | |
| P478 | volume | 11 |
Search more.